Skip to main content
. 2023 Mar 2;15(3):810. doi: 10.3390/pharmaceutics15030810

Figure 3.

Figure 3

Impact of risk score on chemotherapy response. The estimated half-maximal inhibitory concentration (IC50) of Cisplatin (A), Doxorubicin (B), 5-Fluorouracil (C), and Mitomycin C (D) for response between the low-risk and high-risk groups. (E) Kaplan–Meier curves of OS in the chemotherapy-treated patients based on risk score.